Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

35

Revenue 2017

Symbicort

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Symbicort was produced by AstraZeneca and Astellas.

GSK files first application for triple COPD therapy

GSK files first application for triple COPD therapy marketplace. It already has data in hand from the FULFIL trial showing it is more effective than AstraZeneca's Symbicort (formoterol and budesonide).

GSK's triple COPD therapy tops Symbicort in phase III trial

GSK's triple COPD therapy tops Symbicort in phase III trial GlaxoSmithKline has continued to build the case for its three-drug combination for chronic obstructive pulmonary disease, saying it outperformed AstraZeneca's Symbicort in a head-to-head study. ... The phase III FULFIL trial compared the once-daily

AstraZeneca sets sights on China with Takeda deal

AstraZeneca sets sights on China with Takeda deal AZ's respiratory franchise is currently headed by asthma and chronic obstructive pulmonary disease (COPD) drug Symbicort (budesonide and formoterol), which made $2.5bn in the first nine months of the

Humira remains top pharma product, but Sovaldi closes in

Humira remains top pharma product, but Sovaldi closes in 2014. . Sales were $6.7bn for the year - a fall of 20% as pricing pressures and competition from products such as AstraZeneca's Symbicort affected its once dominant market share.

Prescribing costs jump in England

Prescribing costs jump in England After Seretide, another respiratory drug from AstraZeneca - Symbicort - saw the second highest spend with £89m, while Novo Nordisk's insulin NovoRapid came in third with the NHS spending £75m on the

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics